| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9329529 | Gynécologie Obstétrique & Fertilité | 2005 | 5 Pages |
Abstract
Discussion and conclusion. - The existence of endometrial polyps - symptomatic or not - does not seem compatible with the prolonged use of tamoxifen treatment owing the estrogen agonist potential effects of tamoxifen and its well-known hyperplastic and carcinogenic properties for the endometrium. The increased risk of endometrial cancer developing in polyps in this iatrogenic context is estimated between 2.5% and 10% in the literature.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
B. Anama Mbatsogo, G. Le Bouëdec, T. Michy, N. Bourdel, G. Fouilloux, J. Dauplat,